Internal Medicine · Pinehurst, NC
NPI
1669414363
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
15 Regional Dr
Pinehurst, NC, 28374
Phone (910) 295-5511
Groups this clinician bills Medicare through
Medicare paid, 2024
$384K
33,009 services
Medicare patients, 2024
929
Average age 76
Drug cost, 2024
$2.0M
19,978 prescriptions
Company payments, 2025
$455
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen A Letizia was code J1439 (injection, ferric carboxymaltose, 1 mg), 15,000 times for 16 patients. In total Kathleen A Letizia billed 33,009 services in 171 codes, and Medicare paid $384K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,000 | 16 | $0.86 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 5,460 | 67 | $20.56 | $112K |
| 99214 Office E&M - Established | Office | 1,202 | 599 | $77.38 | $93K |
| 36415 Venipuncture Blood Collection | Office | 1,090 | 564 | $8.65 | $9,429 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 786 | 490 | $11.35 | $8,921 |
| 80053 Clinical Chemistry | Office | 597 | 522 | $10.31 | $6,156 |
| 80061 Clinical Chemistry | Office | 564 | 500 | $13.09 | $7,382 |
| 85027 Blood Count | Office | 522 | 489 | $6.32 | $3,301 |
| 84443 Clinical Chemistry | Office | 353 | 242 | $16.40 | $5,787 |
| 83036 Blood Count | Office | 352 | 212 | $9.48 | $3,336 |
| 82306 Clinical Chemistry | Office | 280 | 256 | $29.01 | $8,123 |
| 84100 Clinical Chemistry | Office | 265 | 240 | $4.61 | $1,222 |
| 82248 Clinical Chemistry | Office | 262 | 237 | $4.88 | $1,279 |
| 80069 Clinical Chemistry | Office | 257 | 201 | $8.46 | $2,174 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 255 | 51 | $4.40 | $1,123 |
By year: 2022 $323K for 22,586 services; 2023 $336K for 29,973 services; 2024 $384K for 33,009 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,090 | 564 | $8.65 | $9,429 |
| 80053 Clinical Chemistry | 597 | 522 | $10.31 | $6,156 |
| 80061 Clinical Chemistry | 564 | 500 | $13.09 | $7,382 |
| 85027 Blood Count | 522 | 489 | $6.32 | $3,301 |
| 84443 Clinical Chemistry | 353 | 242 | $16.40 | $5,787 |
| 83036 Blood Count | 352 | 212 | $9.48 | $3,336 |
| 82306 Clinical Chemistry | 280 | 256 | $29.01 | $8,123 |
| 84100 Clinical Chemistry | 265 | 240 | $4.61 | $1,222 |
| 82248 Clinical Chemistry | 262 | 237 | $4.88 | $1,279 |
| 80069 Clinical Chemistry | 257 | 201 | $8.46 | $2,174 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen A Letizia prescribed most often to Medicare patients was Amlodipine Besylate, with 1,468 prescriptions and refills. In total Kathleen A Letizia wrote 19,978 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,468 | 4,030 | 388 | $8,646 |
| Rosuvastatin Calcium Generic | 823 | 2,364 | 241 | $11K |
| Atorvastatin Calcium Generic | 765 | 2,181 | 207 | $8,073 |
| Omeprazole Generic | 722 | 1,810 | 226 | $9,276 |
| Levothyroxine Sodium Generic | 659 | 1,812 | 168 | $7,217 |
| Lisinopril Generic | 486 | 1,382 | 129 | $3,832 |
| Duloxetine Hcl Generic | 474 | 1,184 | 134 | $9,522 |
| Gabapentin Generic | 413 | 856 | 118 | $5,298 |
| Simvastatin Generic | 399 | 1,095 | 105 | $3,623 |
| Metoprolol Succinate Generic | 394 | 1,097 | 113 | $5,855 |
| Valsartan Generic | 391 | 1,097 | 111 | $12K |
| Eliquis Apixaban | 381 | 576 | 67 | $323K |
| Losartan Potassium Generic | 351 | 967 | 96 | $3,565 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 351 | 941 | 90 | $14K |
| Lovastatin Generic | 301 | 885 | 82 | $4,598 |
Brand drugs: 2,572 claims; generic drugs: 17,296 claims; opioid claims: 277.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen A Letizia $455 ($455 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $61.59.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $61.59 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $53.58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49.66 |
| Grifols USA, LLC | 2 | $43.29 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $42.78 |
| Lilly USA, LLC LLY | 2 | $32.06 |
| Abiomed JNJ | 1 | $30.85 |
| Amgen Inc. AMGN | 2 | $28.06 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $20.55 |
| Insulet Corporation PODD | 1 | $18.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.